3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Rhabdomyosarcoma
8
Wilms Tumor
6
Sarcoma
6
Malignant mesenchymal tumor
4
Rhabdomyosarcoma, Embryonal
2
Kidney Neoplasms
2
Hydatidiform Mole
2
Stage I Mixed Cell Type Kidney Wilms Tumor
1
Sarcoma, Ewing
1
Rhabdomyosarcoma, Alveolar
1
Pleuropulmonary blastoma
1
Gestational Trophoblastic Disease
1
Fibrosarcoma
1
Choriocarcinoma
1
Carcinoma, Renal Cell
1
Beckwith-Wiedemann Syndrome
1
Interventions
Vincristine
3
Ifosfamide
3
Etoposide
3
Doxorubicin
3
Cyclophosphamide
3
Surgical Procedures, Operative
2
Specimen Handling
2
Radiotherapy
2
Melphalan
2
Irinotecan
2
Busulfan
2
regorafenib
1
irinotecan sucrosofate
1
X-Rays
1
Trabectedin
1
Temozolomide
1
Radiation
1
Phantoms, Imaging
1
Magnetic Resonance Spectroscopy
1
Fluorodeoxyglucose F18
1
Dactinomycin
1
Bone Density
1
Biopsy
1
Absorptiometry, Photon
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
NETWORK
×
Sarcoma, Ewing
×
Dactinomycin
×
Clear all
NCT02063022
2022-09-19
EW-1
Italian Sarcoma Group
Phase 3
Completed
278 enrolled